NEDD9 is genetically associated with Alzheimer's disease in a Han Chinese population

Brain Research

Volumn 1369, Issue , 2011, Pages 230-234

  Xing, Yao Yao ^a   Yu, Jin Tai ^a   Yan, Wen Jing ^a   Chen, Wei ^a   Zhong, Xiao Ling ^a   Jiang, Hong ^b   Wang, Ping ^a   Tan, Lan ^a  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Alzheimer's disease; Developmentally downregulated 9 (NEDD9); Genetic association; Neural precursor cell expressed; Polymorphism

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN NERVE CELL; CAUCASIAN; CHINESE; CONTROLLED STUDY; DEVELOPMENTALLY DOWNREGULATED 9 GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE OF ONSET; AGED; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PHOSPHOPROTEINS; POLYMORPHISM, GENETIC;

EID: 78651244913     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.113     Document Type: Article

References (34)

1. J.B. Aquino, F. Lallemend, F. Marmigere, I.I. Adameyko, E.A. Golemis, and P. Ernfors The retinoic acid inducible Cas-family signaling protein Nedd9 regulates neural crest cell migration by modulating adhesion and actin dynamics Neuroscience 162 2009 1106 1119
2. S.D. Bargon, P.W. Gunning, and G.M. O'Neill The Cas family docking protein, HEF1, promotes the formation of neurite-like membrane extensions Biochim. Biophys. Acta 1746 2005 143 154
3. J.C. Breitner, K.A. Welsh, B.A. Gau, W.M. McDonald, D.C. Steffens, A.M. Saunders, K.M. Magruder, M.J. Helms, B.L. Plassman, and M.F. Folstein Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance Arch. Neurol. 52 1995 763 771
4. K.H. Buetow, M. Edmonson, and R. MacDonald High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Proc. Natl Acad. Sci. USA 98 2001 581 584
5. J. Chapuis, F. Moisan, G. Mellick, A. Elbaz, P. Silburn, F. Pasquier, D. Hannequin, C. Lendon, D. Campion, P. Amouyel, and J.C. Lambert Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease Hum. Mol. Genet. 17 18 2008 2863 2867
6. F.F. Cruz-Sánchez, X. Gironès, A. Ortega, F. Alameda, and J.V. Lafuente Oxidative stress in Alzheimer's disease: a topographical study J. Neurol. Sci. 299 2010 163 167
7. G.G. Donohoe, A. Salomäki, and T. Lehtimäki Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis Clin. Chem. 45 1999 143 146
8. P. Eikelenboom, R. Veerhuis, W. Scheper, A.J. Rozemuller, W.A. van Gool, and J.J. Hoozemans The significance of neuroinflammation in understanding Alzheimer's disease J. Neural Transm. 113 2006 1685 1695 (Pubitemid 44657664)
9. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., and van Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium JAMA 278 16 1997 1349 1356
10. M. Gatz, N.L. Pedersen, S. Berg, B. Johansson, K. Johansson, J.A. Mortimer, S.F. Posner, M. Viitanen, B. Winblad, and A. Ahlbom Heritability for Alzheimer's disease: the study of dementia in Swedish twins J. Gerontol. Biol. Sci. Med. Sci. 52 1997 M117 M125
11. M. Gatz, C.A. Reynolds, L. Fratiglioni, B. Johansson, J.A. Mortimer, S. Berg, A. Fiske, and N.L. Pedersen Role of genes and environments for explaining Alzheimer disease Arch. Gen. Psychiatry 63 2006 168 174
12. J.M. Gregoire, and P.H. Romeo T-cell expression of the human GATA-3 gene is regulated by a non-lineage-specific silencer J. Biol. Chem. 274 10 1999 6567 6578
13. C.H. Kim, H.S. Kim, J.F. Cubells, and K.S. Kim A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2α-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene J. Biol. Chem. 274 10 1999 6507 6518
14. C.Y. Kuan, A.J. Schloemer, A. Lu, K.A. Burns, W.L. Weng, M.T. Williams, K.I. Strauss, C.V. Vorhees, R.A. Flavell, R.J. Davis, F.R. Sharp, and P. Rakic Hypoxia-ischemia induces DNA synthesis without cell proliferation in dying neurons in adult rodent brain J. Neurosci. 24 2004 10763 10772
15. S. Kumar, Y. Tomooka, and M. Noda Identification of a set of genes with developmentally down-regulated expression in the mouse brain Biochem. Biophys. Res. Commun. 185 1992 1155 1161
16. J.C. Lambert, S. Heath, G. Even, D. Campion, K. Sleegers, M. Hiltunen, O. Combarros, D. Zelenika, M.J. Bullido, B. Tavernier, L. Letenneur, K. Bettens, C. Berr, F. Pasquier, N. Fievet, P. Barberger-Gateau, S. Engelborghs, P. De Deyn, I. Mateo, A. Franck, S. Helisalmi, E. Porcellini, O. Hanon, M.M. de Pancorbo, C. Lendon, C. Dufouil, C. Jaillard, T. Leveillard, V. Alvarez, P. Bosco, M. Mancuso, F. Panza, B. Nacmias, P. Bossu, P. Piccardi, G. Annoni, D. Seripa, D. Galimberti, D. Hannequin, F. Licastro, H. Soininen, K. Ritchie, H. Blanche, J.F. Dartigues, C. Tzourio, I. Gut, C. Van Broeckhoven, A. Alperovitch, M. Lathrop, and P. Amouyel Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease Nat. Genet. 41 2009 1094 1099
17. M.A. Lawson, D.B. Whyte, and P.L. Mellon GATA factors are essential for activity of the neuron-specific enhancer of the gonadotropin-releasing hormone gene Cell. Mol. Biol. 16 1996 3596 3605
18. Y. Li, A. Grupe, C. Rowland, P. Holmans, R. Segurado, R. Abraham, L. Jones, J. Catanese, D. Ross, and K. Mayo Evidence that common variation in NEDD9 is associated with susceptibility to lateonset Alzheimer's and Parkinson's disease Hum. Mol. Genet. 17 2008 759 767
19. E. Martin-Rendon, S.J. Hale, D. Ryan, D. Baban, S.P. Forde, M. Roubelakis, D. Sweeney, M. Moukayed, A.L. Harris, and K. Davies Transcriptional profiling of human cord blood CD133t and cultured bone marrow mesenchymal stem cells in response to hypoxia Stem Cells 25 2006 1003 1012
20. G. McKhann, D. Drachman, and M. Folstein Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
21. Mohandas E., Rajmohan V., and Raghunath B. Neurobiology of Alzheimer's disease Indian J. Psychiatry 51 1 2009 55 61 Jan.
22. Selkoe D.J. Alzheimer's disease is a synaptic failure Science 298 2002 789 791
23. Querfurth H.W., and LaFerla F.M. Alzheimer's disease N. EngI. J. Med. 362 2010 329 344
24. J. Rashidian, G.O. Iyirhiaro, and D.S. Park Cell cycle machinery and stroke Biochim. Biophys. Acta 1772 2007 484 493
25. T. Sasaki, S. Iwata, H.J. Okano, Y. Urasaki, J. Hamada, H. Tanaka, N.H. Dang, H. Okano, and C. Morimoto Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia Stroke 36 2005 2457 2462
26. D.J. Selkoe Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein J. Alzheimers Dis. 3 2001 75 80
27. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
28. R.E. Tanzi A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders J. Clin. Invest. 104 1999 1175 1179
29. Tedde A., Bagnoli S., Piaceri I., Lucenteforte E., Bessi V., Bracco L., Mugelli A., Sorbi S., and Nacmias B. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease Neurosci. Lett. 25, 477 3 2010 121 123
30. T. Vogel, S. Ahrens, N. Büttner, and K. Krieglstein Transforming growth factor beta promotes neuronal cell fate of mouse cortical and hippocampal progenitors in vitro and in vivo: identification of Nedd9 as an essential signaling component Cereb. Cortex 20 3 2010 661 671
31. Y. Wen, S.H. Yang, R. Liu, E.J. Perez, A.M. Brun-Zinkernagel, and P. Koulen Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats Biochim. Biophys. Acta 1772 2007 473 483
32. J.T. Yu, L. Li, Q.X. Zhu, Q. Zhang, W. Zhang, Z.C. Wu, J. Guan, and L. Tan Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease Clin. Chim. Acta 411 19-20 2010 1516 1519
33. C. Zekanowski, and U. Wojda Aneuploidy, chromosomal missegregation, and cell cycle reentry in Alzheimer's disease Acta Neurobiol. Exp. 69 2009 232 253
34. Q. Zhang, J.T. Yu, Q.X. Zhu, W. Zhang, Z.C. Wu, D. Miao, and L. Tan Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease Brain Res. 1348 2010 216 221